What's Happening?
Recent data from the NHS Business Services Authority indicates a rise in the number of medications prescribed to care home residents in England from 2020/2021 to 2024/2025. The analysis shows that 22% of residents over 65 were prescribed ten or more unique
medications in 2024/2025, up from 19% in 2020/2021. The average number of medications per resident also increased. Despite this, the proportion of patients on medications that increase fall risk or should be stopped in case of dehydration remained unchanged. The data highlights the growing complexity of managing medications for older adults in care settings.
Why It's Important?
The increase in medication prescribing in care homes raises concerns about polypharmacy and its potential risks, such as adverse drug reactions and hospital admissions. This trend underscores the need for careful medication management and regular reviews to ensure that treatments are beneficial and not harmful. The findings highlight the importance of involving pharmacy teams in patient care to optimize medication use and improve health outcomes for elderly residents. Addressing these issues is crucial for enhancing the quality of care and reducing healthcare costs associated with medication-related complications.
What's Next?
Healthcare providers and policymakers may need to implement strategies to address polypharmacy in care homes, such as structured medication reviews and deprescribing initiatives. These efforts could involve collaboration between pharmacists, doctors, and care staff to ensure safe and effective medication use. The data may also prompt further research into the impact of polypharmacy on health outcomes and the development of guidelines to manage complex medication regimens in older adults. Ongoing monitoring and evaluation will be essential to assess the effectiveness of interventions and improve care quality.
